Transgenic Group Inc. (TYO:2342)
Japan flag Japan · Delayed Price · Currency is JPY
178.00
-4.00 (-2.20%)
Nov 18, 2026, 10:47 AM JST

Transgenic Group Revenue

Transgenic Group had revenue of 3.41B JPY in the quarter ending September 30, 2026, with 12.65% growth. This brings the company's total for the last twelve months to 14.02B, up 8.52% year-over-year. In the fiscal year ending March 31, 2026, Transgenic Group had annual revenue of 13.17B with 1.30% growth. That makes Transgenic Group the 23,734th largest company in the world by revenue and 2,546th in Japan.

Revenue (ttm)
14.02B
Revenue Growth
+8.52%
P/S Ratio
0.22
Revenue / Employee
61.76M
Employees
227
Market Cap
2.96B

Revenue Chart

Revenue by Segment

  • Investment and Consulting Business 10.92B 82.9%
  • Drug Discovery Support Business 2.26B 17.1%
Fiscal year ended Mar 31, 2026 See the full Transgenic Group breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202613.17B169.00M1.30%
Mar 31, 202513.01B-78.00M-0.60%
Mar 31, 202413.08B1.65B14.47%
Mar 31, 202311.43B-1.15B-9.12%
Mar 31, 202212.58B1.53B13.85%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.